Source: 3D Printing Industry

AMBER: AMBER to develop 3D bioprinted implants for arthritic patients

The Advanced Materials + BioEngineering Research (AMBER) center, headquartered in Dublin, Ireland, is undertaking a project to develop 3D bioprinted implants for people suffering from osteoarthritis. Made to regenerate rather than replace diseased joints, these implants could be an innovative solution for medical problems that affect over 900,000 people in the Republic of Ireland, and around 28.9% of [...]

Read full article »
AMBER's Competitors | AMBER's News | AMBER's Financials
Stay up-to-date with the latest news on Advanced Materials and BioEngineering Research
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Colm McAtamney's photo - General Manager of Advanced Materials and BioEngineering Research

General Manager

Colm McAtamney

CEO Approval Rating

71/100

Read more
Stay up-to-date with the latest news on Advanced Materials and BioEngineering Research